return to +ve ebitda then less depreciation as no generics anymore
- Forums
- ASX - By Stock
- MYX
- PROJECTED $28 million EBITDA +ve in FY24
MYX
mayne pharma group limited
Add to My Watchlist
2.72%
!
$5.01

PROJECTED $28 million EBITDA +ve in FY24, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.01 |
Change
-0.140(2.72%) |
Mkt cap ! $408.6M |
Open | High | Low | Value | Volume |
$5.05 | $5.09 | $5.00 | $173.2K | 34.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 10137 | $5.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.02 | 3483 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 5162 | 5.010 |
7 | 10711 | 5.000 |
5 | 1999 | 4.990 |
4 | 825 | 4.980 |
4 | 856 | 4.970 |
Price($) | Vol. | No. |
---|---|---|
5.020 | 1309 | 5 |
5.030 | 1732 | 7 |
5.040 | 1035 | 3 |
5.050 | 1030 | 6 |
5.060 | 809 | 5 |
Last trade - 12.57pm 31/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |